News about Kansas environmental issues

Here Are 50 Ways To Spend Your Weekend If Youre Bored, Lonely, And Restless

By Hatice Yardım These hobbies from Ask Reddit are perfect for spicing up boring […]

read more

Sumo Logic acquires JASK to fill security operations gap

Sumo Logic, a mature security event management startup with a valuation over $1 billion, announced today that it has acquired JASK, a security operations startup that raised almost $40 million. The companies did not share the terms of the deal.

Sumo’s CEO Ramin Sayar says the combined companies give customers a complete security solution. Sumo offers what’s known in industry parlance as a security information and event management (SIEM) tool, while JASK provides a security operations center or SOC (pronounced “sock“). Both are focused on securing workloads in a cloud native environment and can work in tandem.

Sayar says that as companies shift workloads to the cloud they need to reevaluate their security tools. “The interesting thing about the market today is that the traditional enterprises are much more aggressively taking a security-first posture as they start to plan for new workloads in the cloud, let alone workloads that they are migrating. Part of that requires them to evaluate their tools, teams and, more importantly, a lot of their processes that they’ve built in and around their legacy systems as well as their SOC,” he said.

He says that combining the two organizations helps customers moving to the cloud automate a lot of their security requirements, something that’s increasingly important due to the lack of highly skilled security personnel. That means the more that software can do, the better.

“We see a lot of dysfunction in the marketplace and the whole movement towards automation really complements and supplements the gap that we have in the workforce, particularly in terms of security folks. This is what JASK has been trying to do for four-plus years, and it’s what Sumo has been trying to do for nearly 10 years in terms of using various algorithms and machine learning techniques to suppress a lot of false alerts, triage the process and help drive efficiency and more automation,” he said.

JASK CEO and co-founder Greg Martin says the shift to the cloud has also precipitated two major changes in the security space that have driven this growing need for security automation. “The perimeter is disappearing and that fundamentally changes how we have to perform cybersecurity. The second is that the footprint of threats and data are so large now that security operations is no longer a human scalable problem,” he said. Echoing Sayar, he says that requires a much higher level of automation.

JASK was founded in 2015, raising $39 million, according to Crunchbase data. Investors included Battery Ventures, Dell Technologies Capital, TenEleven Ventures and Kleiner Perkins. Its last round was a $25 million Series B led by Kleiner in June 2018.

JASK nets $25M from Kleiner to build out autonomous security operations

Deepak Jeevankumar, managing director at Dell Technologies Capital, whose company was part of JASK’s Series A investment and who invests frequently in security startups, sees the two companies joining forces as a strong combination.

Sumo Logic and JASK have the same mission to disrupt today’s security industry, which suffers from legacy security tools, siloed teams and alert fatigue. Both companies are pioneers in cloud-native security and share the same maniacal customer focus. Sumo Logic is therefore a great culture and product fit for JASK to continue its journey,” Jeevankumer told TechCrunch.

Sumo has raised $345 million, according to the company. It was valued at over $1 billion in its most recent funding round last May, when it raised $110 million.

CRN first reported this deal was in the works in an article on October 22.

Read more:


Doctor ‘carried out hundreds of needless procedures’

Media playback is unsupported on your device

Media caption‘It was a life changing diagnosis’

The suspended Belfast neurologist Michael Watt carried out hundreds of unnecessary procedures on patients, a BBC Spotlight investigation has revealed.

Dr Michael Watt worked at the Royal Victoria Hospital as a neurologist diagnosing conditions like epilepsy and Parkinson’s Disease.

He is currently suspended from practising medicine.

It follows about 3,000 patients being given recall appointments last year.

Dr Watt was responsible for a huge spike in the number of epidural blood patches carried out in the Belfast Trust in 2015 and 2016.

A blood patch is a rare neurological treatment, usually for patients with a condition called spontaneous intracranial hypotension.

A report by the Department of Health, details of which have been obtained by Spotlight, says that almost none of the patients on whom Dr Watt carried out blood patches had the condition he was treating them for.

Image caption BBC Spotlight’s Conor Spackman spoke to some of Dr Watt’s patients

In 2018, almost 3,000 of Dr Watt’s patients were recalled for a fresh assessment of their care.

Last week, Spotlight reported that one in five was told at the recall they had been misdiagnosed.

A blood patch involves injecting the patient’s own blood into their spine.

Spotlight’s research indicates that Michael Watt carried out 261 blood patches in a nine-year period from 2009 to 2017 inclusive, more than 160 of which were over two years, 2015 and 2016.

To put the figure in context, the programme sent a Freedom of Information request to 150 health trusts across the UK asking them how many blood patches they carried out in 2015 and 2016.

Ninety-six responded and analysis of their responses reveals that Michael Watt was carrying out more blood patches than any of them.

‘Extraordinarily high’

A blood patch expert at the Countess of Chester Hospital in Cheshire, Dr Simon Bricker, told Spotlight that blood patches are normally done by anaesthetists.

He said the numbers being done by Dr Watt were “extraordinarily high” and “somebody doing epidural blood patches in very large numbers should raise red flags straightaway”.

The programme also heard testimony which suggested Michael Watt may not have carried out blood patches in sterile conditions, which Dr Bricker said was “crucial” when doing a blood patch.

One patient, Therese Ward, described how she contracted meningitis after one of her blood patches, while another two were excruciatingly painful.

Image copyright Getty Images/fotostorm

Dr Bricker told Spotlight that meningitis is a risk of a botched blood patch.

He added that the procedure, when done properly, should be largely painless.

‘Traumatic experiences’

Therese Ward gave permission for the Belfast Trust to respond publicly to Spotlight’s questions about her care.

Despite that, the Trust said it was unable to publicly discuss what it called the “personal and traumatic experiences” described by some of Dr Watt’s patients.

It did not respond to questions about what it knew of Michael Watt’s blood patches during the time of the spike.

It said that blood patches are carried out with an aseptic non-touch technique in a clean environment.

It added that a report into Michael Watt’s care had recommended a new local guideline for blood patches which had recently been implemented.

Image caption Dr Simon Bricker told Spotlight that blood patches are normally done by anaesthetists

Spotlight has also revealed that Michael Watt’s enthusiasm for blood patches was first curtailed because of the intervention of a GP.

In late 2016, a Comber-based physician noticed that several of his patients were receiving blood patches.

He didn’t think they needed them and told the Belfast Trust.

Six months later, in summer 2017, Dr Watt was removed from clinical duties.

The recall of patients followed an investigation by the Royal College of Physicians.

The Department of Health said that it is frustrated with the situation.

“While we fully recognise that the delay in the release of the outcomes report – for reasons outside our control – is hugely frustrating for former patients of Dr Watt, we must emphasise that all recalled patients will have had direct dialogue with clinicians as regards their own diagnosis,” it said.

In early 2019, Dr Watt was suspended from practising medicine.

A spokesperson for the PSNI said: “We are aware of the recall of neurology patients by the Belfast Health and Social Care Trust and have met with senior officials within the Department of Health to discuss the issue.

“The Department has agreed to provide us with further information so that we can assess how best to move forward and to enable us to determine if any potential criminal offences can be identified.”

Read more: